Literature DB >> 24051936

Decreased circulating endothelial progenitor cell levels in patients with heart failure with preserved ejection fraction.

Chia-Hung Chiang1, Po-Hsun Huang, Hsin-Bang Leu, Chien-Yi Hsu, Ko-Fan Wang, Jaw-Wen Chen, Shing-Jong Lin.   

Abstract

OBJECTIVES: The purpose of this study was to explore the relationship between endothelial progenitor cell (EPC) levels, heart failure with preserved ejection fraction (HFpEF) and heart failure with reduced ejection fraction (HFrEF).
METHODS: A total of 44 HFpEF patients, 40 HFrEF patients and 69 age-, gender- and comorbidity-matched controls were enrolled after evaluating their clinical manifestations and echocardiography findings. Flow cytometry with quantification of three EPC markers in peripheral blood samples was used to assess the number of circulating EPCs.
RESULTS: HFpEF and HFrEF patients had significantly decreased circulating EPC levels compared to controls. Among heart failure patients, patients with New York Heart Association functional class (FC) IV had fewer circulating EPCs compared to those with FC II and FC III (p = 0.053). A simple linear regression analysis of data showed that high sensitivity C-reactive protein, left ventricular ejection fraction, left atrium diameter and the ratio of medial early filling to early diastolic mitral annular velocity all correlated with the EPC count. In multivariate Cox regression analyses, both HFpEF and HFrEF were found to be independent predictors of a decreased EPC number.
CONCLUSIONS: HFpEF and HFrEF patients have decreased circulating EPC numbers, which is an indication of impaired endothelial turnover.
Copyright © 2013 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2013        PMID: 24051936     DOI: 10.1159/000351973

Source DB:  PubMed          Journal:  Cardiology        ISSN: 0008-6312            Impact factor:   1.869


  12 in total

1.  Involvement of NADPH oxidases and non-muscle myosin light chain in senescence of endothelial progenitor cells in hyperlipidemia.

Authors:  Ting-Bo Li; Jie-Jie Zhang; Bin Liu; Wei-Qi Liu; Yan Wu; Xiao-Ming Xiong; Xiu-Ju Luo; Qi-Lin Ma; Jun Peng
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2015-12-19       Impact factor: 3.000

2.  Association between echocardiographic epicardial fat thickness and circulating endothelial progenitor cell level in patients with stable angina pectoris.

Authors:  Ting-Yung Chang; Chien-Yi Hsu; Chun-Chih Chiu; Ruey-Hsing Chou; Hsin-Lei Huang; Chin-Chou Huang; Hsin-Ban Leu; Po-Hsun Huang; Jaw-Wen Chen; Shing-Jong Lin
Journal:  Clin Cardiol       Date:  2017-05-02       Impact factor: 2.882

3.  Progenitor Cells and Clinical Outcomes in Patients With Heart Failure.

Authors:  Ayman Samman Tahhan; Muhammad Hammadah; Pratik B Sandesara; Salim S Hayek; Andreas P Kalogeropoulos; Ayman Alkhoder; Heval Mohamed Kelli; Matthew Topel; Nima Ghasemzadeh; Kaavya Chivukula; Yi-An Ko; Hiroshi Aida; Iraj Hesaroieh; Ernestine Mahar; Jonathan H Kim; Peter Wilson; Leslee Shaw; Viola Vaccarino; Edmund K Waller; Arshed A Quyyumi
Journal:  Circ Heart Fail       Date:  2017-08-08       Impact factor: 8.790

4.  Aging-Related Endothelial Progenitor Cell Dysfunction and Its Association with IL-17 and IL-23 in HFmrEF Patients.

Authors:  Lijin Zeng; Cong Zhang; Guoyi Cai; Bin Zhang; Zixia Huang; Mingyue Wu; Yuanting Zhu; Liang Luo; Hao He; Zhen Yang
Journal:  Oxid Med Cell Longev       Date:  2022-06-26       Impact factor: 7.310

5.  Endothelial Progenitor Cell Response to Acute Multicomponent Exercise Sessions with Different Durations.

Authors:  Suiane Cavalcante; Manuel Teixeira; Ana Duarte; Miriam Ferreira; Maria I Simões; Maria Conceição; Mariana Costa; Ilda P Ribeiro; Ana Cristina Gonçalves; José Oliveira; Fernando Ribeiro
Journal:  Biology (Basel)       Date:  2022-04-09

Review 6.  Endothelial Progenitor Cells in Heart Failure: an Authentic Expectation for Potential Future Use and a Lack of Universal Definition.

Authors:  Andie H Djohan; Ching-Hui Sia; Poay Sian Lee; Kian-Keong Poh
Journal:  J Cardiovasc Transl Res       Date:  2018-05-17       Impact factor: 4.132

Review 7.  Circulating stem cells and cardiovascular outcomes: from basic science to the clinic.

Authors:  Gian Paolo Fadini; Anurag Mehta; Devinder Singh Dhindsa; Benedetta Maria Bonora; Gopalkrishna Sreejit; Prabhakara Nagareddy; Arshed Ali Quyyumi
Journal:  Eur Heart J       Date:  2020-11-21       Impact factor: 29.983

8.  Endothelial Progenitors and Blood Microparticles: Are They Relevant to Heart Failure With Preserved Ejection Fraction?

Authors:  Eduard Shantsila; Gregory Y H Lip
Journal:  EBioMedicine       Date:  2016-01-19       Impact factor: 8.143

Review 9.  Endothelial Progenitor Cells: An Appraisal of Relevant Data from Bench to Bedside.

Authors:  Doralisa Morrone; Maria Elena Lucia Picoi; Francesca Felice; Andrea De Martino; Cristian Scatena; Paolo Spontoni; Antonio Giuseppe Naccarato; Rossella Di Stefano; Uberto Bortolotti; Massimo Dal Monte; Stefano Pini; Marianna Abelli; Alberto Balbarini
Journal:  Int J Mol Sci       Date:  2021-11-28       Impact factor: 5.923

Review 10.  Cell Therapy in Heart Failure with Preserved Ejection Fraction.

Authors:  Sabina Frljak; Gregor Poglajen; Bojan Vrtovec
Journal:  Card Fail Rev       Date:  2022-03-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.